Brain Stimulation Effects on Post-Stroke Fatigue and Aphasia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSyracuse University
About this trial
The goal of this clinical trial is to determine if electrical brain stimulation applied to the front parts of the brain can help people who have had a stroke improve their fatigue, language, and attention. The main question it aims to answer is:
* Does transcranial direct current stimulation (tDCS) administered to the pre-frontal areas of the brain improve post-stroke fatigue and aphasia? * What kinds of participant characteristics are associated with better improvement of post-stroke fatigue and aphasia?
Researchers will compare active electrical stimulation to sham stimulation to see if the active stimulation does a better job at reducing fatigue and language deficits after stroke. Participants will be asked to complete fatigue, language, and cognitive testing before and after receiving 10 sessions of tDCS plus speech and language therapy.
Eligibility criteria
Qualifiers
18 years or older.
No diagnosis of neurological disorder (other than stroke).
No diagnosis of psychiatric disorder, with the exception of anxiety and/or depression if it is managed through medication and/or behavioral intervention.
No seizure within the past 6 months.
Disqualifiers
Younger than 18 years old.
Diagnosis or history of neurological disorder other than stroke.
Diagnosis or history of psychiatric disorder with the exception of anxiety and/or depression if it is managed through medication and/or behavioral intervention.
History of seizures within the past 6 months.
Trial design
Treatments tested in this trial
- tDCS (active)
- Attention-focused sentence comprehension treatment
- Sentence comprehension treatment
- tDCS (sham)
Treatment groups
60 Participants
are divided into 4 treatment groupsSponsors and collaborators
Syracuse University
Lead sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
Source ClinicalTrials.gov